Year archive

Akeso, Inc. — 2023 filings

All 43 regulatory filings released by Akeso, Inc. (9926) in 2023, sourced directly from the official regulator.

43 Filings

2023 Period

2023 filings (43)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2023 Regulatory Filings	2023-12-06	English
VOLUNTARY ANNOUNCEMENT - AK104-303, A PHASE III TRIAL OF CADONILIMAB REACHED PROGRESSION-FREE-SURVIVAL (PFS) PRIMARY ENDPOINT AT INTERIM ANALYSIS FOR FIRST LINE TREATMENT OF CERVICAL CANCER Regulatory Filings	2023-11-23	English
VOLUNTARY ANNOUNCEMENT - AK104-302, A PHASE III TRIAL OF CADONILIMAB IN COMBINATION WITH CHEMOTHERAPY AS FIRST LINE TREATMENT FOR GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA (GC/GEJC) RE Regulatory Filings	2023-11-07	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2023 Regulatory Filings	2023-11-06	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2023 Regulatory Filings	2023-10-06	English
2023 INTERIM REPORT Regulatory Filings	2023-09-26	English
GRANT OF SHARE OPTIONS Regulatory Filings	2023-09-06	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2023 Regulatory Filings	2023-09-05	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023 Regulatory Filings	2023-08-29	English
VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION ACCEPTED THE NEW DRUG APPLICATION FOR THE EBDAROKIMAB INJECTION (IL-12/IL-23 MONOCLONAL ANTIBODY, AK101) INDEPENDENTLY-DEVELO Regulatory Filings	2023-08-24	English
DATE OF BOARD MEETING Regulatory Filings	2023-08-15	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2023 Regulatory Filings	2023-08-02	English
INSIDE INFORMATION ANNOUNCEMENT POSITIVE PROFIT ALERT Regulatory Filings	2023-07-31	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2023 Regulatory Filings	2023-07-05	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON WEDNESDAY, JUNE 28, 2023 Regulatory Filings	2023-06-28	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON WEDNESDAY, JUNE 28, 2023 Regulatory Filings	2023-06-02	English
NOTICE OF ANNUAL GENERAL MEETING Regulatory Filings	2023-06-02	English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; PROPOSED RE-ELECTION OF RETIRING DIRECTORS; PROPOSED RE-APPOINTMENT OF AUDITORS; AND NOTICE OF ANNUAL GENERA Regulatory Filings	2023-06-02	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2023 Regulatory Filings	2023-06-02	English
VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION HAS ACCEPTED THE NEW DRUG APPLICATION FOR EBRONUCIMAB INJECTION (ANTI-PCSK9 MONOCLONAL ANTIBODY, AK102) DEVELOPED BY AKESO Regulatory Filings	2023-06-02	English
FIFTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Regulatory Filings	2023-05-19	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON FRIDAY, MAY 19, 2023 Regulatory Filings	2023-05-19	English
VOLUNTARY ANNOUNCEMENT - AKESO'S PARTNER SUMMIT THERAPEUTICS ANNOUNCES FIRST PATIENT TREATED IN PHASE III HARMONI CLINICAL TRIAL EVALUATING IVONESCIMAB (PD-1/VEGF BISPECIFIC ANTIBODY) Regulatory Filings	2023-05-10	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2023 Regulatory Filings	2023-05-04	English
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING Regulatory Filings	2023-05-03	English
NOTICE OF EXTRAORDINARY GENERAL MEETING Regulatory Filings	2023-05-03	English
(1) PROPOSED RMB SHARE ISSUE UNDER SPECIFIC MANDATE (2) PROPOSED AMENDMENTS TO ARTICLES OF ASSOCIATION AND (3) NOTICE OF THE EXTRAORDINARY GENERAL MEETING Regulatory Filings	2023-05-03	English
CHANGE OF ROLE OF SENIOR MANAGEMENT Regulatory Filings	2023-04-28	English
PROPOSED ISSUE OF RMB SHARES ON THE STAR MARKET UNDER SPECIFIC MANDATE; PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND CLOSURE PERIOD OF REGISTER OF MEMBERS Regulatory Filings	2023-04-28	English
NOTICE OF PUBLICATION OF ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT FOR THE YEAR ENDED 31 DECEMBER 2022 Regulatory Filings	2023-04-27	English
2022 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT Regulatory Filings	2023-04-27	English
2022 ANNUAL REPORT Regulatory Filings	2023-04-27	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2023 Regulatory Filings	2023-04-04	English
DIS-APPLICATION OF RULES 18A.09 TO 18A.11 OF THE LISTING RULES AND REMOVAL OF STOCK MARKER Regulatory Filings	2023-03-22	English
TERMS OF REFERENCE OF THE REMUNERATION COMMITTEE Regulatory Filings	2023-03-16	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022 Regulatory Filings	2023-03-16	English
VOLUNTARY ANNOUNCEMENT - SECOND TRANCHE OF UPFRONT PAYMENT RECEIVED UNDER THE LICENSE AGREEMENT FOR IVONESCIMAB (PD-1/VEGF BISPECIFIC) WITH SUMMIT THERAPEUTICS INC. Regulatory Filings	2023-03-06	English
DATE OF BOARD MEETING Regulatory Filings	2023-03-03	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 28 February 2023 Regulatory Filings	2023-03-03	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2023 Regulatory Filings	2023-02-03	English
VOLUNTARY ANNOUNCEMENT - FIRST TRANCHE OF UPFRONT PAYMENT RECEIVED UNDER THE LICENSE AGREEMENT FOR IVONESCIMAB (PD-1/VEGF BISPECIFIC) WITH SUMMIT THERAPEUTICS INC. Regulatory Filings	2023-01-26	English
INSIDE INFORMATION ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION APPROVES MARKETING APPROVAL OF ANNIKO (PENPULIMAB) COMBINED WITH CHEMOTHERAPY AS THE FIRST LINE TREATMENT OF LOCALLY ADV Regulatory Filings	2023-01-16	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2022 Regulatory Filings	2023-01-04	English